ClinicalTrials.gg
CompletedNCT07890779Updated Oct 22, 2026

Ultrasound-Guided Ulnar Versus Radial Artery Cannulation in Children

An interventional study of Radial artery cannulation and Ulnar artery cannulation in Arterial Catheterization, Hemodynamic Monitoring and Pediatrics, sponsored by Tunis University. Completed at 1 site in Tunisia. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Tunis University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Jan 2024, registered Oct 2026).
Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
85
Allocation
Randomized
Ages
1 Year to 18 Years
Sex
All
01

Study summary

Arterial catheterization provides continuous blood pressure monitoring and repeated blood sampling in children undergoing surgery at high cardiovascular or hemorrhagic risk, and in critically ill children. The radial artery is the conventional site, but cannulation remains challenging in children because of small vessel caliber and frequent anatomical variants. Ultrasound guidance has made alternative sites accessible, and the ulnar artery has a comparable caliber and a depth often closer to the range considered optimal for puncture. This trial compared ultrasound-guided ulnar versus radial arterial cannulation in children older than one year, with regard to first-attempt success and the rate of local complications.

Read the detailed description

Children older than one year, of ASA physical status I to III, requiring invasive arterial pressure monitoring for elective surgery or in the intensive care unit, were randomly assigned in a 1:1 ratio to cannulation of the radial artery (group R) or the ulnar artery (group U). The allocation sequence was computer-generated and applied by an investigator not involved in the puncture, after sedation had been established. Patients and their legal guardians remained unaware of the allocated site; operators could not be blinded. The allocated artery was screened sonographically before puncture to exclude thrombosis or anatomical variants, and its diameter and depth were measured. The wrist was placed in 45 degrees of dorsiflexion. The artery was punctured on the anterior aspect of the wrist through a short-axis out-of-plane approach, using a 25-gauge 4 cm catheter and a 6-13 MHz linear probe, by anesthesia residents in their seventh semester of training or beyond under direct senior supervision. An attempt was considered failed when a large hematoma or arterial spasm occurred; cannulation was then reattempted at the same arterial site on the contralateral limb, and the supervising senior physician took over in case of persistent failure.

02

Conditions studied

  • Arterial Catheterization
  • Hemodynamic Monitoring
  • Pediatrics

Keywords

  • ulnar artery
  • radial artery
  • arterial cannulation
  • ultrasound guidance
  • out-of-plane
  • children
03

In context

Lead sponsor

Tunis University is the lead sponsor of 22 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age older than one year - physical status I to III - Need for invasive arterial pressure monitoring during elective surgery or in the intensive care unit - Written from the legal guardian

Exclusion criteria

Exclusion Criteria:

  • Refusal or unavailability of the legal guardian at the time of the pre-anesthetic assessment - Arterial catheterization at the same site within the preceding month - to arterial catheterization: inflammatory, ischemic or infectious lesions of both upper limbs, dialysis fistula - Abnormal Allen test - Hemostatic disorder - Treatment with catecholamines above 0.1 microgram per kilogram per minute - Wrist arterial malformation identified at sonographic screening
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
85 participants (actual)

Study arms

  • Active comparator
    Radial artery (Group R)

    Ultrasound-guided cannulation of the radial artery through a short-axis out-of-plane approach.

    Procedure: Radial artery cannulation

  • Experimental
    Ulnar artery (Group U)

    Ultrasound-guided cannulation of the ulnar artery through a short-axis out-of-plane approach.

    Procedure: Ulnar artery cannulation

Interventions

  • ProcedureRadial artery cannulation

    The radial artery is identified sonographically at the anterior aspect of the wrist and confirmed with Doppler, with the wrist in 45 degrees of dorsiflexion. It is punctured through a short-axis out-of-plane approach using a 25-gauge 4 cm catheter and a Sonosite M-Turbo system with a 6-13 MHz linear probe.

  • ProcedureUlnar artery cannulation

    Identical procedure applied to the ulnar artery.

06

What researchers measure

Primary outcomes

  1. Successful arterial cannulation at the first attempt

    Proportion of patients in whom an arterial pressure waveform was obtained on the monitor at the first puncture attempt

    Time frame: During the cannulation procedure, up to 15 minutes from skin puncture

Secondary outcomes

  1. Artery localization time

    Time frame: During the cannulation procedure, up to 15 minutes

  2. Catheter insertion time

    Time frame: During the cannulation procedure, up to 15 minutes

  3. Total procedure time

    Time frame: During the cannulation procedure, up to 15 minutes

  4. Number of puncture attempts

    Time frame: During the cannulation procedure, up to 15 minutes

  5. Need for a second operator

    Time frame: During the cannulation procedure, up to 15 minutes

  6. Incidence of local complications

    Time frame: From the cannulation procedure until catheter removal, up to 7 days

07

Study locations

1 site
  • Bechir Hamza Children's Hospital, Tunis 1029
    Tunis, 1029, Tunisia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07890779
Lead sponsor
Tunis University
Responsible party
Mehdi Trifa (Professor, Tunis University) — Principal investigator
First posted
Oct 22, 2026
Start date
Jan 1, 2024
Primary completion
Sep 1, 2024
Completion
Sep 1, 2024
Last update
Oct 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion